{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:36:02Z","timestamp":1793644562721,"version":"4.5.1"},"reference-count":52,"publisher":"American Society for Clinical Investigation","issue":"14","funder":[{"name":"Sanofi","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,26]]},"abstract":"<jats:p>\n                    The neuropathological effects of phenylketonuria (PKU) stem from the inability of the body to metabolize excess phenylalanine (Phe), resulting in accumulation of Phe in the blood and brain. Since the kidney normally reabsorbs circulating amino acids with high efficiency, we hypothesized that preventing the renal uptake of Phe might provide a disposal pathway that could lower systemic Phe levels. SLC6A19 is a neutral amino acid transporter responsible for absorption of the majority of free Phe in the small intestine and reuptake of Phe by renal proximal tubule cells. Transgenic KO mice lacking SLC6A19 have elevated levels of Phe and other amino acids in their urine but are otherwise healthy. Here, we crossed the\n                    <jats:italic>Pah<\/jats:italic>\n                    <jats:sup>enu2<\/jats:sup>\n                    mouse model of PKU with the\n                    <jats:italic>Slc6a19<\/jats:italic>\n                    -KO mouse. These mutant\/KO mice exhibited abundant excretion of Phe in the urine and an approximately 70% decrease in plasma Phe levels. Importantly, brain Phe levels were decreased by 50%, and the levels of key neurotransmitters were increased in the mutant\/KO mice. In addition, a deficit in spatial working memory and markers of neuropathology were corrected. Finally, treatment of\n                    <jats:italic>Pah<\/jats:italic>\n                    <jats:sup>enu2<\/jats:sup>\n                    mice with\n                    <jats:italic>Slc6a19<\/jats:italic>\n                    antisense oligonucleotides lowered Phe levels. The results suggest that inhibition of SLC6A19 may represent a novel approach for the treatment of PKU and related aminoacidopathies.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.121762","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T11:01:04Z","timestamp":1532516464000},"source":"Crossref","is-referenced-by-count":55,"title":["Inhibiting neutral amino acid transport for the treatment of phenylketonuria"],"prefix":"10.1172","volume":"3","author":[{"given":"Adam M.","family":"Belanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Przybylska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Gefteas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Furgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Kloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson S.","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"B1"},{"issue":"1","key":"B2","first-page":"31","article-title":"Phenylketonuria: an inborn error of phenylalanine metabolism","volume":"29","author":"Williams","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"B3","unstructured":"Donlon J, Sarkissian C, Levy H, Scriver CR. In: Beaudet AL, et al, eds. The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: The McGraw-Hill Companies, Inc.; 2014. https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62673211 Accessed July 20, 2018"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22980"},{"key":"B5","unstructured":"Blau N, Th\u00f6ny B, Cotton RGH, Hyland K. In: Beaudet AL, et al, eds. The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: The McGraw-Hill Companies, Inc.; 2014. https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62673465 Accessed July 20, 2018"},{"key":"B6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99 Suppl 1","author":"Anderson","year":"2010","journal-title":"Mol Genet Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.20.11014"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0583-1"},{"issue":"1","key":"B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/IJAMH.2004.16.1.41","article-title":"Blood phenylalanine control in adolescents with phenylketonuria","volume":"16","author":"Walter","year":"2004","journal-title":"Int J Adolesc Med Health"},{"key":"B10"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2"},{"key":"B12","first-page":"23","article-title":"Maternal phenylketonuria: long-term outcomes in offspring and post-pregnancy maternal characteristics","volume":"21","author":"Waisbren","year":"2015","journal-title":"JIMD Rep"},{"issue":"1","key":"B13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/j.2040-4603.2014.tb00550.x","article-title":"Transport of amino acids in the kidney","volume":"4","author":"Makrides","year":"2014","journal-title":"Compr Physiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2006"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400904200"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature05475"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00325.2006"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.648519"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.055"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.241323"},{"issue":"4","key":"B21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","article-title":"Mouse models of human phenylketonuria","volume":"134","author":"Shedlovsky","year":"1993","journal-title":"Genetics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023498508987"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-14-06175.1999"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200212200-00036"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200004270-00042"},{"key":"B26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01799701","article-title":"Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function","volume":"9 Suppl 2","author":"G\u00fcttler","year":"1986","journal-title":"J Inherit Metab Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9473-2"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9417-2"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2015.0827"},{"key":"B30","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2011.07.010","article-title":"Oxidative stress in phenylketonuric patients","volume":"104 Suppl","author":"Vargas","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.03.005"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.09.038"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/BF00692698"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320440412"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710001288"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2006.05.025"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-05-01880.1997"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.120"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2015.02.003"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.070086"},{"issue":"12","key":"B41","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.bbamem.2010.02.012","article-title":"Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy","volume":"1798","author":"Moulton","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ng1406"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ng1405"},{"key":"B44","unstructured":"Levy HL. In: Beaudet AL, et al, G eds. The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: The McGraw-Hill Companies, Inc.; 2014. https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62654267 Accessed July 20, 2018"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80216-2"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/adc.52.1.38"},{"issue":"5","key":"B47","first-page":"401","article-title":"The Hartnup phenotype: Mendelian transport disorder, multifactorial disease","volume":"40","author":"Scriver","year":"1987","journal-title":"Am J Hum Genet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9269-1"},{"key":"B49","unstructured":"Mitchell GA, Grompe M, Lambert M, Tanguay RM. In: Beaudet AL, et al, eds. The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: The McGraw-Hill Companies, Inc.; 2014. https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62673883 Accessed July 20, 2018"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55780-9_19"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21357"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00553-3"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/121762\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:58:51Z","timestamp":1779195531000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/121762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":52,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2018,7,25]]},"published-print":{"date-parts":[[2018,7,26]]}},"alternative-id":["10.1172\/jci.insight.121762"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.121762","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"article-number":"e121762"}}